Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia. Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, et al. Blood 2020 Jun 23. pii: 461100. doi: 10.1182/blood.2019004292.

Read + Share

Amedeo Smart

Independent Medical Education

Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, et al. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia. Blood 2020 Jun 23. pii: 461100. doi: 10.1182/blood.2019004292.
PMID: 32573733